CTT Pharmaceutical Holdings, Inc. (CTTH)

CTTH Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2014	FY 2014
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2014	Feb 28, 2014
Selling, General & Admin	0.17	0.12	0.24	0.04	0.66	0.01
Amortization of Goodwill & Intangibles	0.01	0.01	0.01	-	-	-
Operating Expenses	0.18	0.13	0.25	0.04	0.66	0.01
Operating Income	-0.18	-0.13	-0.25	-0.04	-0.66	-0.01
Interest Expense	-0	-0	-	-	-	-
Other Non Operating Income (Expenses)	-0.03	-0.03	-	-	-0.01	-0
Pretax Income	-0.21	-0.16	-0.25	-0.04	-0.67	-0.02
Net Income	-0.21	-0.16	-0.25	-0.04	-0.67	-0.02
Net Income to Common	-0.21	-0.16	-0.25	-0.04	-0.67	-0.02
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	58	58	52	51	16	0
Shares Outstanding (Diluted)	58	58	52	51	16	0
Shares Change	-	9.92%	3.65%	209.26%	6435.55%	-98.32%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.04	-0.07
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.04	-0.07
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2014	FY 2014
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2014	Feb 28, 2014
EBITDA	-0.17	-0.12	-0.24	-0.04	-	-
D&A For EBITDA	0.01	0.01	0.01	0.01	-	-
EBIT	-0.18	-0.13	-0.25	-0.04	-0.66	-0.01

Data Source: S&P Global Market Intelligence Last updated: Sep 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 28, 2026

Data Sources Report a data error